Campbell L, Ibrahim F, Barbini B, Samarawickrama A, et al. Bone mineral density, kidney function and participant-reported outcome measures in women who switch from tenofovir disoproxil emtricitabine and a nonnucleoside reverse transcriptase inhibitor to abacavir, lamivudine and dolutegravir. HIV Med 2021 Dec 5. doi: 10.1111/hiv.13215.
PMID: 34866304